Taprostene - Moligand™, ≥95% , Agonist of IP receptor, CAS No.108945-35-3, Agonist of IP receptor

CAS: 108945-35-3 Cat. No.: T340466 Formula: C24H30O5 Molecular Weight: 398.49 PubChem CID: 5311243
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥95%
Synonyms
HY-114671 | Taprostene | SCHEMBL364129 | AKOS040758543 | J-002212 | Q27088939 | Rheocyclan | Taprosteno | Taprosteno [Spanish] | DTXSID50872496 | Taprostene [INN] | 3-((Z)-((3aR,4R,5R,6aS)-4-((S,E)-3-Cyclohexyl-3-hydroxyprop-1-en-1-yl)-5-hydroxyhexahydro-
Storage
Store at 2-8°C
Shipped In
Wet ice
★
Size
USA
Germany (EU)*
Price
Qty
1mg
T340466-1mg
Made to order · 8–12 wks
$579.90
5mg
T340466-5mg
Made to order · 8–12 wks
$1,449.90
Enter a quantity for the sizes you want to add.
🧪
Why this grade

Moligand™, ≥95% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at 2-8°C Ships Wet ice Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Taprostene is a highly selective agonist to the IP|1|prostanoid receptor. It is a stable prostacyclin (PGI|2|) analog.

Specifications

Synonyms
HY-114671 | Taprostene | SCHEMBL364129 | AKOS040758543 | J-002212 | Q27088939 | Rheocyclan | Taprosteno | Taprosteno [Spanish] | DTXSID50872496 | Taprostene [INN] | 3-((Z)-((3aR,4R,5R,6aS)-4-((S,E)-3-Cyclohexyl-3-hydroxyprop-1-en-1-yl)-5-hydroxyhexahydro-
Specifications & Purity
Moligand™, ≥95%
Storage
Store at 2-8°C
Shipped In
Wet ice
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
AGONIST
Mechanism of action
Agonist of IP receptor
Purity
≥95%
Names and Identifiers
Canonical Smiles
C1CCC(CC1)C(C=CC2C(CC3C2CC(=CC4=CC(=CC=C4)C(=O)O)O3)O)O
IUPAC Name
3-[(Z)-[(3aR,4R,5R,6aS)-4-[(E,3S)-3-cyclohexyl-3-hydroxyprop-1-enyl]-5-hydroxy-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]methyl]benzoic acid
InChIKey
ZLJOKYGJNOQXDP-OZUBPDBUSA-N
INCHI
1S/C24H30O5/c25-21(16-6-2-1-3-7-16)10-9-19-20-13-18(29-23(20)14-22(19)26)12-15-5-4-8-17(11-15)24(27)28/h4-5,8-12,16,19-23,25-26H,1-3,6-7,13-14H2,(H,27,28)/b10-9+,18-12-/t19-,20-,21-,22-,23+/m1/s1
Isomeric SMILES
C1CCC(CC1)[C@@H](/C=C/[C@H]2[C@@H](C[C@H]3[C@@H]2C/C(=C/C4=CC(=CC=C4)C(=O)O)/O3)O)O
PubChem CID
5311243
Molecular Weight
398.49

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassBenzoic acids and derivatives
Intermediate Tree Nodes Not available
Direct ParentBenzoic acids
Alternative Parents Benzoyl derivatives  Tetrahydrofurans  Secondary alcohols  Cyclic alcohols and derivatives  Oxacyclic compounds  Monocarboxylic acids and derivatives  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Benzoic acid - Benzoyl - Cyclic alcohol - Tetrahydrofuran - Secondary alcohol - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Oxacycle - Organoheterocyclic compound - Hydrocarbon derivative - Organic oxygen compound - Organooxygen compound - Organic oxide - Alcohol - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as benzoic acids. These are organic Compounds containing a benzene ring which bears at least one carboxyl group.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
PTGIR Tclin Prostacyclin receptor (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilitySoluble in Water: 26 mg/mL
Molecular Weight398.500 g/mol
XLogP34.000
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count5
Exact Mass398.209 Da
Monoisotopic Mass398.209 Da
Topological Polar Surface Area87.000 Ų
Heavy Atom Count29
Formal Charge0
Complexity635.000
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds2
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested applications, recommended dilutions, or protocol specifics are provided in the Product Data for this item.

General protocol framework for small-molecule ligands (non-specification)

  • Stock preparation: Dissolve in dry DMSO (or other suitable solvent) to 10–50 mM. Vortex and, if needed, sonicate briefly. Filter through 0.22 μm if particulate persists and the compound is not adsorptive.
  • Working solutions: Dilute into buffer or culture medium to the desired final concentration, maintaining a constant vehicle percentage across conditions.
  • Controls: Include vehicle-only control and, where possible, a positive control ligand for the pathway of interest.
  • Stability: Use freshly prepared dilutions. Minimize light exposure and keep on ice during setup if stability is uncertain.
  • Documentation: Record lot number, stock concentration, vehicle percent, and preparation date.

Always adapt to your specific assay and consult the SDS/CoA for restrictions.

Biological Roles

Item-specific biological targets or mechanisms are not provided in the Product Data. This product is supplied for research use only.

General background (literature-based, non-specification)

  • Synthetic analogs in the prostanoid family are commonly used as chemical biology tools to interrogate eicosanoid signaling pathways, second-messenger formation, gene expression programs, and receptor pharmacology in vitro.
  • Typical experimental readouts include modulation of intracellular cAMP/cGMP, changes in kinase activity, and transcriptional reporters. Outcomes are assay- and cell-type dependent.

Good practices for biological experiments

  • Establish a concentration–response curve with appropriate vehicle controls.
  • Confirm on-target pathway engagement using orthogonal assays (e.g., second-messenger quantification and downstream gene expression).
  • Include selectivity panels or counter-screens to evaluate off-target effects.
  • Record and report co-solvent percentage, exposure time, and temperature to facilitate reproducibility.

Note: No clinical or therapeutic claims are made for this product; it is intended solely for laboratory research.

Buffer Applications

This product is a small-molecule ligand and is not a buffering agent. Conventional buffer system guidance (e.g., phosphate, HEPES, Tris) is not directly applicable.

Practical handling notes

  • Prepare stocks in appropriate organic solvent (commonly DMSO or ethanol) and dilute into the chosen biological buffer or cell culture medium, ensuring the final co-solvent percentage is compatible with the assay.
  • If precipitation occurs upon dilution, increase the dilution steps, warm gently, or include a small percentage of co-solvent as permitted by the assay design.
  • Document buffer composition (pH, ionic strength) alongside ligand concentration for reproducibility.
Green Alternatives

As a research ligand listed in a compound library, Taprostene itself does not have a direct “green alternative.” However, greener choices can be made in solvent and handling.

Greener solvent choices (general guidance)

  • Prefer lower-toxicity, biodegradable, and renewable solvents when compatible with your assay, such as ethanol or 2-propanol for intermediate stocks, or water with cyclodextrin carriers for delivery—recognizing potential assay interference.
  • Reduce DMSO volumes where feasible; keep final assay DMSO ≤0.1–0.5% v/v to minimize biological effects.

Comparison (general, non-specification)

  • DMSO: High solvency; not renewable; moderate toxicity; excellent for freezer-stable stocks.
  • Ethanol: Renewable and biodegradable; flammable; lower solvency than DMSO.
  • 2-MeTHF/CPME (for synthetic steps, if any): Bio-based/greener ether options vs. THF/Et2O; evaluate compatibility with functional groups present in the molecule.

Operational green practices

  • Prepare concentrated stocks to minimize solvent waste per assay.
  • Use amber vials and cold storage to extend solution life and reduce remake frequency.
  • Plan micro-scale assays to reduce consumables and chemical usage.
Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation designation is provided for this item. It is supplied strictly for research use only.

General formulation considerations for research materials (non-specification)

  • For in vitro work: Use solvent stocks (e.g., DMSO) and dilute into assay buffer or media. Validate that vehicle concentrations do not impact the biological system.
  • For ex vivo/tissue studies: Consider co-solvent systems (e.g., PEG400/saline, ethanol/cremophor/saline) only if permitted by your protocols and institution; pre-validate stability and compatibility.
  • For stability: Protect solutions from light and elevated temperature; aliquot to avoid freeze–thaw where possible.

No therapeutic claims are made for this product, and it is not intended for any clinical or diagnostic use.

Physical Properties
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD: Not specified for this item; refer to CoA/Spec Sheet.

Literature/general notes (non-specification)

  • Small-molecule prostacyclin analogs are commonly handled as lipophilic acids or salts that dissolve well in polar aprotic organic solvents (e.g., DMSO) and co-solvent mixtures for aqueous work. Actual solubility and partitioning are structure-dependent; consult the item CoA before preparing stock solutions.
  • For accurate method development (e.g., LC–MS), determine the compound’s UV spectrum and ionization behavior experimentally; do not rely on class-wide assumptions.
Quality & Grades
  • Grade/Purity: Moligand™ (as provided). This designation indicates inclusion in a curated small-molecule/compound library suitable for discovery screening and mechanistic studies.

What Moligand™ implies (general guidance)

  • Emphasis on identity confirmation (e.g., LC–MS and/or NMR) and suitability for biochemical and cell-based screening workflows.
  • Attention to handling and packaging that supports reproducible assay performance (e.g., controlled storage, minimized moisture/oxygen exposure, aliquoting options where applicable).

Item-specific details

  • Exact assay purity, residual solvents, water content, and stabilizers: Not specified for this item; refer to CoA/Spec Sheet.
  • Intended use: For research use only (from Product Data). Not for drug, diagnostic, or household use.

Recommendations to users

  • Request the current CoA/specification sheet for batch-specific purity and analytical data prior to regulated or quantitative studies.
  • If low-UV background or metal content are critical to your application, confirm those parameters explicitly on the batch CoA, as they are not specified here.
Reaction & Applications

Manufacturer-provided application notes are not specified for this item. The product is listed within a small-molecule/compound library category and is intended for research use only.

General research applications for small-molecule ligands (non-specification)

  • Chemical biology: probe studies to interrogate signaling pathways, receptor–ligand interactions, or transcriptional responses using dose–response and time-course designs.
  • Screening: primary/secondary screening in biochemical or cell-based assays; counter-screens to assess selectivity and off-targets.
  • Analytical reference: internal standards or method development controls in LC–MS workflows when appropriate.

If using in chemical synthesis

  • No item-specific reactivity data are provided. If derivatization is planned (e.g., for probe conjugation), determine functional group profile from NMR/LC–MS first and select coupling strategies accordingly (e.g., amide coupling if a carboxylate is present). Validate that transformations do not compromise the intended biological activity.

Always confirm application scope and limits from the CoA/SDS and perform pilot experiments to establish working concentrations and stability under your conditions.

Reaction Conditions

No item-specific reaction conditions or transformation guidance are provided for this product, which is listed as a small-molecule research ligand.

If performing chemical modifications (general, non-specification)

  • Solvents: Choose polar aprotic media (DMF, DMSO, NMP) to enhance solubility of lipophilic, multifunctional molecules.
  • Temperature: Begin at ambient temperature; escalate cautiously while monitoring by TLC/LC–MS for degradation.
  • Atmosphere: Use inert gas (N2/Ar) for moisture/oxygen-sensitive motifs.
  • Workup: Quench carefully and extract with suitable biphasic systems; consider solid-phase extraction to remove high-boiling solvents.
  • Purification: Reverse-phase preparative HPLC is often effective for complex, lipophilic small molecules; confirm purity by orthogonal methods (NMR, HRMS).

All conditions must be optimized empirically once the molecule’s functional groups are confirmed from the CoA and analytical data.

Safety & Handling
  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / pictograms: Not specified for this item; refer to SDS.
  • Storage conditions (item-specific): Store at 2–8°C (from Product Data). Shipments are sent on wet ice.

General laboratory precautions (non-SDS guidance)

  • Handle in a chemical fume hood, avoiding inhalation and skin/eye contact. Wear appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves.
  • Avoid exposure to strong oxidizers and bases/acids until compatibility is confirmed from SDS/CoA.
  • Prepare solutions freshly or aliquot and minimize freeze–thaw cycles to limit degradation of functionalized lipophilic ligands.

First-aid overview (consult SDS for authoritative guidance)

  • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation persists.
  • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
  • Ingestion: Rinse mouth; seek medical attention.

Waste and spill response

  • Absorb small spills with inert material; collect for disposal as organic chemical waste in accordance with institutional and local regulations.
  • Decontaminate surfaces with suitable organic solvent followed by detergent and water, as permitted by the SDS.
Solvent Selection

Item-specific solubility data are not provided for this product; consult the CoA/SDS before preparing solutions.

General solvent guidance for lipophilic small-molecule ligands (literature-based, non-specification)

  • Stock solutions: DMSO is commonly used for 10–50 mM stocks due to broad solvency and assay compatibility. Ethanol or isopropanol are alternatives when DMSO is undesirable.
  • Aqueous working solutions: Prepare by serial dilution into buffered media containing co-solvent (e.g., 0.1–1% DMSO or EtOH) and/or carrier proteins (e.g., BSA) as permitted by your assay. Verify compatibility with your biological system.
  • Non-aqueous chemistry uses: If employing in synthetic manipulations or derivatizations, polar aprotic solvents (DMF, DMAc, NMP, DMSO) improve solubility; choose based on reactivity and downstream workup.

Comparison notes (general)

  • DMSO: maximal solubility and stability for many lipophilic acids; may affect some biological readouts above ~0.5% v/v.
  • Ethanol: broadly compatible but lower solvency; flammable and more volatile.
  • PEG400 or aqueous cyclodextrin: useful vehicle for higher aqueous loading; assess assay interference.

Practical tips

  • Filter or centrifuge to remove particulates after dissolution.
  • Document final co-solvent percentages in assay records for reproducibility.
Storage & Reconstitution
  • Storage (item-specific): Store at 2–8°C. Shipped on wet ice (from Product Data).
  • Reconstitution: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance (non-specification)

  • Allow container to equilibrate to room temperature in a desiccator before opening to prevent moisture condensation.
  • For solid materials: Weigh quickly and prepare a concentrated stock in dry DMSO or suitable solvent. For liquids/oils: Pre-dilute by volume using calibrated pipettes.
  • Aliquot stocks into amber, airtight vials to minimize freeze–thaw and light exposure. Store aliquots at 2–8°C or frozen if stability allows (verify on CoA/SDS).
  • Label with compound name, lot, solvent, concentration, and date. Monitor for precipitation or discoloration over time.

Stability testing

  • Establish an internal stability profile (e.g., periodic LC–MS or HPLC assay of stored stocks) to confirm suitability for long studies.

For authoritative instructions on reconstitution and long-term storage, consult the batch-specific CoA/SDS.

Structure & Identity
  • Product name: Taprostene (SKU: T340466)
  • CAS: 108945-35-3; PubChem CID: 5311243
  • InChIKey: 460149 (as provided in Product Data)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Item-specific structure annotations: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/general description (non-specification): Taprostene is described in the literature as a synthetic analog related to the prostacyclin (PGI2) chemotype used as a small-molecule ligand in receptor/pathway studies. Typical prostacyclin analogs feature a carboxylic acid (or prodrug thereof), multiple aliphatic stereocenters, and oxygenated functional groups; exact features for this item should be confirmed from the CoA/SDS.

Identity verification best practices

  • Cross-check CAS and CID against internal reference databases and the supplied CoA.
  • Use orthogonal identity tests where appropriate (e.g., high-resolution MS for exact mass; 1H/13C NMR for fingerprinting; LC–MS retention vs. reference standard).
Synthetic Utility

This product is offered as a research ligand rather than as a synthetic building block; item-specific functional group information and reactivity are not provided.

General guidance if derivatization is contemplated (non-specification)

  • Determine functional groups by NMR/LC–MS first. If a carboxylic acid is present, standard coupling chemistries (e.g., EDC/HOBt, HATU) may enable amide formation to link reporter tags or affinity handles.
  • Protect sensitive alcohols or conjugated motifs if multi-step chemistry is planned; assess stability to acids/bases and oxidants prior to scale-up.
  • Consider bioconjugation strategies (e.g., click chemistry) only after confirming the presence of compatible handles and evaluating the impact of modification on biological activity.

Note: Without item-specific specifications, all synthetic manipulations should be piloted on sub-milligram scale to assess stability and purity outcomes.

Target Specificity

Target, pathway, or receptor specificity is not provided in the Product Data for this item.

User guidance

  • If employing this compound as a probe, determine target engagement with orthogonal assays (binding, functional readouts) and include appropriate controls.
  • Document literature sources and internal data supporting any target assignments in your experimental records.

For any definitive claims of target specificity, rely on primary literature data and the batch CoA; no such claims are made here.

Need help choosing the grade?

Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.

View Moligand™ grade guide →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.